CA 15-3

This test is a blood test used to measure the level of cancer antigen 15-3 (CA 15-3), a protein that may be elevated in individuals with breast cancer. It is primarily used to monitor treatment effectiveness and detect recurrence in patients already diagnosed with breast cancer.

The purpose of this test is to:

• Measure CA 15-3 levels in the blood
• Monitor breast cancer treatment and progression
• Detect recurrence of breast cancer
• Evaluate response to therapy
• Support diagnosis along with other medical tests

CA 15-3 Test Purpose

The CA 15-3 (Cancer Antigen 15-3) Test measures the level of CA 15-3, a protein released into the bloodstream by certain breast cancer cells. It is primarily used as a tumor marker to monitor breast cancer, assess the effectiveness of treatment, detect cancer recurrence, and evaluate disease progression. While CA 15-3 is most commonly associated with breast cancer, elevated levels may also be seen in other cancers and certain non-cancerous conditions.

Healthcare providers commonly recommend the CA 15-3 Test for individuals who have been diagnosed with breast cancer, particularly advanced or metastatic breast cancer. The test helps monitor how well treatments such as surgery, chemotherapy, radiation therapy, targeted therapy, or hormone therapy are working. A decreasing CA 15-3 level may indicate that treatment is effective, whereas increasing levels may suggest disease progression or recurrence.

Furthermore, the CA 15-3 Test is not recommended as a screening test for breast cancer in healthy individuals because early-stage breast cancer may not cause elevated CA 15-3 levels. Additionally, increased CA 15-3 levels can occur in other cancers, including lung, ovarian, liver, pancreatic, and colorectal cancers, as well as in non-cancerous conditions such as liver disease, benign breast disorders, endometriosis, and pregnancy. Therefore, the results should always be interpreted in the context of the patient’s overall clinical condition.

This Test is often performed alongside CEA (Carcinoembryonic Antigen), CA 27.29, mammography, breast ultrasound, breast MRI, PET-CT, and other imaging studies to provide a comprehensive evaluation of breast cancer and its response to treatment.

This Test is Recommended for Individuals:

• Patients diagnosed with breast cancer.
• Individuals undergoing chemotherapy, radiation therapy, hormone therapy, or targeted therapy for breast cancer.
• Patients requiring monitoring for breast cancer recurrence.
• Individuals with metastatic breast cancer.
• Patients advised by their oncologist to monitor treatment response.
• Individuals undergoing follow-up after breast cancer treatment.
• Patients requiring tumor marker evaluation as part of cancer management.

FAQs

1. What is the CA 15-3 Test used for?

This Test measures the level of Cancer Antigen 15-3 in the blood. It is mainly used to monitor breast cancer treatment, assess disease progression, and detect cancer recurrence, especially in patients with advanced breast cancer.

2. Do I need to fast before the CA 15-3 Test?

No. Fasting is generally not required for the CA 15-3 Test. However, always follow any specific instructions provided by your healthcare provider before sample collection.

3. Does a high CA 15-3 level always mean breast cancer?

No. An elevated CA 15-3 level does not always indicate breast cancer. It may also occur in other cancers or non-cancerous conditions, including liver disease, benign breast disorders, endometriosis, and pregnancy. Your healthcare provider will interpret the results together with your symptoms, imaging findings, medical history, and other diagnostic tests to determine the underlying cause.